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Abstract
We generalize the Susceptible-Infected-Removed model for epidemics to take into account generic
effects of heterogeneity in the degree of susceptibility to infection in the population. We introduce
a single new parameter corresponding to a power-law exponent of the susceptibility distribution
that characterizes the population heterogeneity. We show that our generalized model is as simple
as the original model which is contained as a limiting case. Because of this simplicity, numerical
solutions can be generated easily and key properties of the epidemic wave can still be obtained
exactly. In particular, we present exact expressions for the herd immunity level, the final size
of the epidemic, as well as for the shape of the wave and for observables that can be quantified
during an epidemic. We find that in strongly heterogeneous populations the epidemic reaches only
a small fraction of the population. This implies that the herd immunity level can be much lower
than in commonly used models with homogeneous populations. Using our model to analyze data
for the SARS-CoV-2 epidemic in Germany shows that the reported time course is consistent with
several scenarios characterized by different levels of immunity. These scenarios differ in population
heterogeneity and in the time course of the infection rate, for example due to mitigation efforts
or seasonality. Our analysis reveals that quantifying the effects of mitigation requires knowledge
on the degree of heterogeneity in the population. Our work shows that key effects of population
heterogeneity can be captured without increasing the complexity of the model. We show that
information about population heterogeneity will be key to understand how far an epidemic has
progressed and what can be expected for its future course.
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I. INTRODUCTION
Diseases that spread by transmission between individuals can give rise to epidemic waves
that pass through a population [1, 2]. One infected person can infect several others who
are susceptible to the infection, characterized by the basic reproduction number R0, initially
typically generating an exponential growth of the number of infections. The number of
infections reaches a peak and later dies down when there is a sufficient number of individuals
that have gained immunity after they recovered from the infection so that further growth
is hampered. The fraction of immune individuals reached at the point when the epidemic
starts to recede is called herd immunity [1, 3, 4].
There are big uncertainties as to when and why an epidemic reaches its peak and the
levels of herd immunity required [5]. Simple models of infections dynamics predict that
for an initially fast growing epidemic most of the population will become infected before
the epidemic dies down [1, 3, 6]. It was noted early by William Farr when investigating
smallpox and other epidemics that epidemics appear to follow a general time course in the
form of a skewed bell shaped curve [7, 8]. They first grow fast, reach a peak and then die
down quickly, typically much before the majority of a population has been affected. The
fact that an epidemic dies down is usually attributed to the fact that there exists some
degree of immunity in the population [9]. The uncertainty about when the peak of an
epidemic is reached and why an epidemic dies out even if there remains a large number
of still susceptible individuals reveals that the factors that limit an epidemic are not well
understood. Furthermore, the effectiveness and impact of mitigation measures such as social
distancing to counter a fast growing epidemic are not known.
Simplified models of infection dynamics, such as the classic Susceptible-Infected-Removed
(SIR) model have been used for a long time to describe the dynamics of epidemics spreading
through a population [1, 3, 6, 10]. Such models capture key features of the epidemic as
a nonlinear wave with qualitative properties that match observed bell-shaped dynamics of
epidemic waves. However, more quantitatively, such models exhibit the robust feature that
a quickly growing epidemic does not stop unless the majority of a susceptible population
has reached immunity after going through the infection [1]. This raises the question whether
important factors are missing in these simple and elegant models. To understand at what
conditions and at what levels epidemic waves become self-limiting and die down remains
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an important challenge. This aspect is also key to understand the role and effectiveness of
social distancing measures to influence dynamics of an epidemic wave [10–12].
Simple epidemic models treat the population as effectively consisting of identical individ-
uals. However, individuals in a population can differ widely. The importance of population
heterogeneity was put forward to understand smallpox epidemic which could not be cap-
tured by simple models [13]. Such heterogeneity has been taken into account by adding
details such as introducing several compartments to a model [14] or by introducing distri-
butions of susceptibility [13, 15] or infectiousness [15, 16]. It was suggested that population
heterogeneity reduces effective herd immunity levels [13, 15, 17, 18].
In this paper, we present a generalization of the SIR model that takes into account effects
of population heterogeneity. We show here that effects of heterogeneity can be added without
losing the simplicity of the SIR model and keeping its mathematical structure. We introduce
a single new parameter, the susceptibility exponent α, which characterizes a generic power-
law heterogeneity in the distribution of infection susceptibilities of the population. Power
laws are often found in nonlinear and complex systems [19–22]. In the present context,
power laws could be expected for example based on a variability of immune responses of
different individuals which could imply a wide variability in the efficiency of the transmission
of an infection [23, 24]. Furthermore, population heterogeneity could be relevant at very
different scales, from the the immune response of cells to the behaviors of individuals that
affect infection rates. Such as broad range of relevant scales could give rise to approximately
scale free properties or power laws.
In the heterogeneous SIR model proposed here, the qualitative behaviors of the the epi-
demic wave are unchanged. However, as a function of the parameter α, the wave can become
self-limited at much lower levels of infected individuals as compared to the classic SIR model.
In the limit of large α we recover the classic SIR model of homogeneous populations. For
smaller α we find that the number of infections at the peak and the cumulative number of
infections after the epidemic has passed can be strongly reduced. Our work has implica-
tions for the concept of herd immunity and clarifies that herd immunity cannot be discussed
independently of population heterogeneity.
We discuss the dynamics of the SARS-CoV-2 pandemics using the heterogeneous SIR
model applied to data on reported infection numbers and COVID-19 associated deaths in
Germany [25]. We estimate parameter values including the susceptibility exponent α and
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Figure 1: Effects of population heterogeneity on the dynamics of SIR models. Examples for the
time course of fraction of susceptible S/N (green), fraction of infected I/N (orange) and fraction
of the cumulative number of infected C/N (blue) in a SIR model with N total individuals. (a)-
(c) Homogeneous SIR model with R0 = 2.5 and γ = 0.13 day
−1. (d)-(f) Heterogeneous SIR
model with same R0 and γ and with α = 0.1. (a) and (d) show time course as linear plot, (b)
and (e) show semi logarithmic plots of the same variables. (c) and (f) show the normalized time
dependent reproduction number R(t)/R0 (yellow) and the average susceptibility x¯(t) (purple) as
a function of time. The dotted lines in (a),(b),(d) and (e) indicate the herd immunity level CI .
Other parameters: N = 8 107 individuals and I0 = 10 initially infected.
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show that the time course observed in Germany is compatible with different scenarios ranging
from a homogeneous population strongly affected by mitigation to a self-limited epidemic
wave in a heterogeneous population where social distancing measures play a minor role.
II. THE SUSCEPTIBLE-INFECTED-REMOVED MODEL
The Susceptible-Infected-Removed (SIR) model captures key features of a spreading epi-
demic as a mean field theory based on pair-wise interactions between infected and susceptible
individuals. This model captures generic and robust features without aiming to describe spe-
cific details. In the presence of I infected individuals in a population of N individuals, the
infection can be transmitted to susceptible individuals. They stay infectious during an aver-
age time γ−1 after which they no longer contribute to infections. The number of susceptible
individuals S and the number of infected individuals I obey
S˙ = −βx¯IS
N
(1)
I˙ = βx¯
IS
N
− γI , (2)
where the dots denote time derivatives, x¯ is a dimensionless average susceptibility and the
rate β(t) describes a probability per unit time and per person to become infected, which can
in general depend on time t. This time dependence could correspond to seasonal changes or
mitigation measures [10, 12, 26]. The cumulative number of infections is C = N −S. A key
parameter is the basic reproduction number
R0 =
β
γ
, (3)
which denotes the average number of new infections generated by an infected individual.
The growth rate of infections is I˙/I = λ(t) = γ(R(t)−1), where R(t) = βx¯S/(Nγ) is a time
dependent reproduction number.
The time course of an epidemic is often provided as the number of new cases per day.
This corresponds to the rate of new infections per unit time
J = βx¯
IS
N
(4)
with J = C˙ = −S˙ and R = J/(γI).
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A. Infection dynamics in homogeneous populations
In the simple case of a homogeneous population, all individuals have the same degree of
susceptibility, x = 1 and the population average of x is x¯ = 1 independent of time. This
is the classic SIR model. An example for a solution to these equations for homogeneous
population x¯ = 1 and constant β is given in Fig. 1 (a),(b). The corresponding time
dependent reproduction number is presented in Fig. 1 (c). The number of infections first
grows exponentially with growth rate
λ0 = γ(R0 − 1) . (5)
As the number of susceptible decreases, the epidemic reaches a peak number of infected
Imax = I(tI) at time t = tI with I˙(tI) = 0 and R(tI) = 1. At this peak, a fraction
SI/N = 1/R0 of individuals remain susceptible. The cumulative number of infections CI at
the maximum of I thus obeys
CI
N
= 1− 1
R0
. (6)
Eq. (6) is the classic herd immunity level which is the fraction of immune individuals in the
population beyond which the epidemic can no longer grow. Finally the epidemic dies down
exponentially with rate
λ∞ = γ
(
R0S∞
N
− 1
)
, (7)
where
S∞
N
= − 1
R0
W (−R0e−R0) (8)
is the fraction of susceptible individuals that remain after long times. Here W (z) denotes
Lambert W-function, see Appendix A. The total fraction of infections over the course of the
epidemic is C∞/N = 1− S∞/N .
For a classic SIR model with homogeneous population we have for R0 = 2.5, a herd
immunity level CI/N of 60% of the population, see Fig. 1 (a),(b). After the infection has
passed C∞/N ' 89% of the population have been infected, see Fig. 2 (a),(b) (green lines).
The fraction of the population that become infected increase for larger R0. The SIR model
thus suggests that for R0 > 2 the epidemic wave exceeds a majority of the population before
the epidemic begins to die out.
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Figure 2: Fraction of susceptible individuals at long times. (a) Fraction S∞/N of susceptible
individuals that remain at long times as a function of the basic reproduction number R0 for different
degrees of population heterogeneity characterized by the values of α. The limit α→∞ corresponds
to the classic case with homogeneous populations (green). In the limit α→ 0 populations are most
heterogeneous (blue). (b) Fraction SI/N of susceptible individuals as a function of R0 at the peak
where the number of infected is maximal for different α. (c) Ratio of infections after the peak
Sm − S∞ and infections before the peak N − Sm as a function of R0.
B. Infection dynamics with population heterogeneity
Not all individuals are the same and for some susceptible individuals the probability
of infection per time is lower than for others. This can be captured by a distribution of
susceptibilities x [13, 15]. We denote s(x)dx the number of individuals with susceptibility
between x and x+ dx. The total number of susceptible individuals is then S =
∫∞
0
dxs(x).
For each sub-population s(x) with susceptibility x, the number of susceptible individuals
decreases as
∂ts = −βxs I
N
, (9)
which for the whole population implies Eq. (1) with average susceptibility
x¯ =
1
S(t)
∫ ∞
0
dx xs(x, t) , (10)
which is in general time dependent.
This time dependence can be discussed by introducing the variable τ that is a measure
for how far the epidemic has advanced. It increases monotonically with time as τ˙ = βI/N .
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Eq. (9) can be then be written as ∂τs = −xs, and the number of susceptible individuals is
S(τ) =
∫ ∞
0
dxs0(x)e
−τx , (11)
where s0(x) is the initial susceptibility distribution at time t = t0 with average x¯ = 1, see
Appendix B.
C. Infection dynamics with generic power law heterogeneity
The dynamics of epidemic waves depends on the shape of the initial distribution s0(x).
Here, we consider distributions that have the special property of shape invariance under the
dynamics of epidemics. This property is satisfied by a gamma distribution
s0(x) ∼ x−1+αe−αx , (12)
which is governed by a power-law at small x, characterized by the exponent α, and a cut
off at large x. The distribution s0(x) has average x¯ = 1 and variance 1/α. Indeed, we have
s(x, t) = x¯−1+αs0(x/x¯), where the time dependence enters via x¯(t), see Appendix C. This
shape invariance implies that the gamma distribution is maintained at all times and is not
merely an initial condition. Furthermore, starting with any initial distribution that exhibits
a power law s0(x) ∼ x−1+α at small x, it will converge for large τ to the shape invariant
gamma distribution, which therefore is an attractor of the dynamics, see Appendix B. Note
that in the limit of large α, we recover the classic SIR model for a homogeneous population.
For small α, the population is strongly heterogeneous.
For the choice (12) we have
S(τ) =
N − I0
(1 + τ
α
)α
. (13)
The average susceptibility is
x¯ =
1
1 + τ
α
, (14)
which starts from x¯ = 1 for τ = 0 and decreases for increasing τ , thus dampening the
epidemic. We can now express the dynamics given in Eqns (1) and (2) as two dynamic
equations for I(t) and τ(t) which read
I˙ = Iβ(1− I0
N
)(1 +
τ
α
)−(α+1) − γI (15)
τ˙ = βI/N . (16)
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Figure 3: (a) Daily new SARS-CoV-2 infections reported in the early months of 2020 in Germany.
The number of new reported infections per day J trep (red symbols) is shown together with the
number of reported infections per day for those cases with later fatal outcome Jfrep (blue symbols).
(b) Semi logarithmic representation of the same data. The dashed and solid lines represent linear
and cubic fits to the data in specific time intervals. They are used to estimate the initial and
final growth rates λ0 and λ∞ as well as A2 = J¨/J and A3 =
...
J /J at the maximum of the rate of
new cases Jmax. We find λ0 ' 0.269 day−1 (0.336 day−1), λ∞ ' −0.068 day−1 (−0.038 day−1),
A2 ' −10−2 day−2 (−0.91 10−2 day−2) and A3 ' 6.8 10−4 day−3 (7.5 10−4 day−3) for the fatal
cases (for all reported cases).
with initial values I(0) = I0, τ(0) = 0 and S(0) = N − I0. The number of susceptible
individuals at time t is then given by S(t) = S(τ(t)). An example of a time course of this
model for α = 0.1 is shown in Fig. 1 (d), (e) and (f).
We can discuss how the shape of the epidemic wave depends on the parameter α. The
epidemic starts out with exponential growth of infected individuals at rate λ0 = γ(R0 − 1),
with R0 = β/γ. The time dependent reproduction number is
R = x¯1+αR0 . (17)
When the reproduction number drops to R = 1, the number of infected reaches a maximum
Imax
N
= 1− 1
R0
− 1
R0
(1 + α)(R
1
1+α
0 − 1) . (18)
Beyond the herd immunity level given by the cumulative number of infections at the maxi-
mum of I
CI
N
= 1−R−
α
α+1
0 , (19)
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the reproduction number R drops below 1 and the epidemic dies down. In Eqns. (17)-(19)
we have considered the limit of small I0/N for simplicity. In the limit of large α, these
expressions converge to those obtained for the homogeneous SIR model, see Appendix A.
The remaining fraction of susceptible individuals at the peak and after the epidemic has
passed is shown as a function of α in Fig. 2(a) and (b). This reveals that as α is reduced,
the fraction of the population reached by the epidemic decreases and can become very small
for small α. At the same time the infections are more spread out over time and a larger
fraction occurs after the peak when α is reduced, see Fig. 2 (c).
An important case is a strongly heterogeneous population. For small α  1, we obtain
simple analytical expressions for the behavior of the system, see Appendix E. In this limit
we have Imax/N ' α(lnR0 + 1/R0 − 1) and CI/N ' α lnR0. An important quantity is the
rate J of new cases per time. For small α it takes the maximal value
Jmax
N
' γα((R0 − 2)e
1
R0
−1
+ 1) (20)
The final number of susceptible individuals is given by
S∞
N
= x¯α∞ , (21)
where for small α the average susceptibility after the infection has passed is x¯∞ '
−1/(R0W−1(−e−1/R0/R0)). Here W−1(z) denotes the −1 branch of Lambert W function.
We finally have for small α
λ∞ = γ(R0x¯∞ − 1) . (22)
A key result is that for small α the herd immunity level can be much below the classical
value suggested by the SIR model. For example for R0 = 2.5 and α = 0.1, we have Imax/N '
2.8%, and a fraction CI/N ' 8% of infected individuals required for herd immunity, much
lower than is usually suggested. The total number of infected at long times is C∞/N ' 14%,
see Appendix C.
III. APPLICATION TO THE SARS-COV-2 EPIDEMIC IN GERMANY
We analyze the dynamics of the SARS-CoV-2 epidemic in Germany using public data
provided by the Robert Koch institute [25]. These daily reports provide the numbers of
reported positive tests for each day, but also the dates of reporting of those infections which
10
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Figure 4: Time course of the SARS-CoV-2 epidemic in Germany (symbols) compared to solutions
of the heterogeneous SIR model (lines). (a) and (b) Data on daily reported infections (red) and on
reported infections with later fatal outcome (blue) as logarithmic and linear plots. (c) and (d) same
data and model solutions as in (a) and (b) but for cumulative numbers of cases. The horizontal
dashed lines indicate scaled herd immunity levels. Parameter values for the model solution are
R0 = 2.67 (R0 = 3.91), γ = 0.146 (γ = 0.069), α = 0.05 and N = 8 10
7 for the fatal cases (for all
cases). The case fatality rate that corresponds to this solution is f = 0.13% ( f = 0.11%). (e) Time
courses of the fraction of infected I/N (blue), the new cases per day J/N (red) and the fraction
of cumulative cases C/N (yellow) for R0 = 2.67 and γ = 0.146. (f) Time course of the average
susceptibility x¯ = (R/R0)
1/(1+α) (blue), where R is the time dependent reproduction number and
of τ = α(1/x¯ − 1) (red) for the solution shown in (e). Inset: distributions of susceptibility in the
population for different values of τ .
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later turn out as fatal. The total number of new reported infections per day J trep (red
symbols) are shown in Fig. 3 (a) together with the number of reported infections per day
that were later fatal (blue symbols), which we denote Jfrep(t). Both sets of data can be
interpreted as proxies for the rate J of new cases per day up to an unknown factor. They
show qualitatively similar behavior, a rapid growth and a decline after passing a maximum.
However there are quantitative differences, in particular the growth rates at early and late
times, given by the slopes of the data in a single logarithmic plot are different, see Fig. 3
(b). The number of new cases per day that are later fatal Jfrep(t) is related to the number
of new infections per day as Jfrep(t) = Jf , where f denotes the infection fatality rate, the
fraction of infections that are fatal, which we consider to be constant for simplicity.
A. Comparison to heterogeneous SIR model
The calculated number of new cases per day J obtained as solution to Eqns. (15) and
(16) for a heterogeneous population and scaled by the factor f to match the data of fatal
cases are shown in Fig. 4 (a)-(d) as solid blue lines. These lines are shown together with the
number Jfrep of new fatal cases per day as blue symbols. The factor f was determined such
that the cumulated cases per day Jfrep/f matches the cumulative number of cases C on June
15. The time axis is chosen such that the model matches the data. From a fit of the model
to the data we obtain the parameter estimates R0 ' 2.67 and γ ' 0.146 day−1. Good fits to
the data are found for a range of α sufficiently small, about α < 0.2. The resulting infection
fatality rates f vary as α is changed. Using α = 0.05 corresponds to an infection fatality
rate f ' 0.13%. It could be larger or smaller if a different value of α was used. This would
not significantly affect the quality of the fit as long as α < 0.2. The calculated time courses
I(t), J(t) and C(t) corresponding to these fits to Jfrep are shown in (e). The dependence of
the average susceptibility x¯ on time and the function τ(t) are shown in (f). The increase of
τ with time represents the advance of the epidemic. The inset in (f) shows the shape of the
distribution of susceptibility in the population at different stages characterized by different
values of τ .
It is surprising that the model fits the data of fatal cases with just two fit parameters
while yielding a reasonable infection fatality rate. This is further clarified when using the fit
values of R0 and γ to calculate λ0 ' 0.24 day−1, slightly smaller than the estimate given in
12
(a) (b) (c)
(d) (e) (f )
Figure 5: Role of population heterogeneity for the behavior of the generalized SIR model. Plots
of various dimensionless ratios of parameters characterizing the shape of the infection wave for
different values of α. Here the limit α→∞ corresponds to the homogeneous SIR model, the limit
α → 0 to the strongly heterogeneous case. Here λ0 and λ∞ denote the initial and final growth
rate, A2 = J¨/J and A3 =
...
J /J describe the shape of the wave at the maximum of new cases per
day J . The horizontal dashed lines correspond to estimates from fits shown in Fig. 3, the shaded
regions indicate uncertainty ranges, see Appendix D.
Fig. 3 (b). Using Eq. (22), we also find λ∞ ' −0.069 day−1, very close to the estimate from
the data. The data of all reported cases can also be captured by the model for small α, see
Fig. 4 (a) and (c) red symbols and red lines. This fit is not as close and the parameter values
are different, see Fig. 4. Our comparison of the model to the data shows that the model
captures the time course of fatal cases surprisingly well for the case of strong heterogeneity
for infection fatality rates that fall in the range of estimates from immunological studies
[27–30].
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B. Quantification of the shape of the epidemic wave
In order to understand how the shape of the wave of infections constrains the possible
parameter values of R0, γ and α, we consider in addition to the initial growth rate λ0 and
the final decay rate λ∞ two coefficients describing the epidemic dynamics near its peak,
using the expansion
ln J(t) ' ln Jmax + A2
2
(t− tJ)2 + A3
6
(t− tJ)3 , (23)
where the linear term disappears by definition at the maximum Jmax = J(tJ) at time tJ .
The coefficients A2 = J¨/J |t=tJ and A3 =
...
J /J |t=tJ can be obtained for the homogeneous
and heterogeneous SIR model, see Appendix A, D and E. Fig. 5 shows dimensionless
combinations of these values as a function of R0 for different α ranging from the homogeneous
case α → ∞ to strongly heterogeneous with α → 0 as solid lines of different color. The
values obtained from the fits shown in Fig. 3 are indicated as dashed lines together with
shaded regions corresponding to estimated uncertainty ranges of these values.
We find that the ratio A2/λ
2
∞, which is independent of γ depends only weakly on α. We
can therefore use it to estimate R0, see Fig. 5. Using A2 ' −0.01 day−2 and λ∞ ' −0.07
day−1 determined from the data of fatal cases, we have A2/λ2∞ ' 2.0 leading to the estimate
R0 ' 2.5, see Fig. 5. This estimate can now be used to infer bounds on α. The ratio
λ∞/λ0 ' −0.3 is only consistent with R0 ≥ 2.6 and the lower value corresponds to the limit
of small α, see Fig. 5. This reveals that α  1 must be small and that the classic SIR
model with homogeneous population is not consistent with this data. We can now estimate
γ using the small α limit. For R0 ' 2.6, we have γ ' 2λ∞ ' 0.14 day−1, see Fig. 5 (d).
The data does not provide information about the true total number of infections. Therefore
the precise value of α remains unknown. We can use estimates from immunological studies
estimating the number of infections [27, 29, 30] to determine α. This suggests a range of
about 0.01 < α < 0.15, corresponding to 0.65% > f > 0.04%. Fig. 5 also shows the
estimated ranges for data on all reported cases in red. For this case the inferred values of
R0 is larger and the consistency with the data is less strong.
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C. Effects of mitigation and social distancing measures
During an epidemic conditions can change over time. For example, mitigation by social
distancing measures, quarantining or seasonal changes could affect how quickly an infection
spreads on average from person to person. Given that such changes are global, they may
be captured by a time-dependence of the rate β(t)[10, 12, 26]. In the following, we discuss
scenarios of mitigated epidemics, starting from a reference point with an initial infection
rate β0 prior to mitigation. We use this reference to define the herd immunity CI of the
population via Eq. (19). The herd immunity level depends on the basic reproduction
number R0 = β0/γ and on the population heterogeneity α. For immunity levels above herd
immunity, C ≥ CI , the population is stable after mitigation measures are completely relaxed
and β is restored to its original value β0.
We examine three different scenarios with a comparable total number of infections. These
scenarios are shown in Fig. 6. They are characterized by different levels of immunity relative
to herd immunity at July 1 and thus differ in the future behaviors beyond this time. Starting
in all scenarios with R0 = 2 and using γ = 0.24, the model follows the initial growth at rate
λ0 of the reported cases. If β is kept constant, β = β0, the model deviates from the data
at later times, see dotted lines in Fig. 6. If β is permitted to change in time, almost any
reported time course could be described by the model. We use the data to infer a time course
of β(t) such that the model follows the data, see Appendix G. The inferred values of β are
shown as circles in Fig. 6 (c), (f) and (i). In order to fit the model to the data in different
mitigation scenarios, we use a piecewise linear modulation of β. The time dependence of
β(t) that resulted from these fits are shown in Fig. 6 (c), (f) and (i) as solid lines. The
value of β decreases sharply at the onset of mitigation. After this decrease it stays roughly
constant or increases at constant rate, thus relaxing mitigation. The magnitude of maximal
mitigation and the two slopes of β(t) were used as fit parameters.
In the case of early mitigation, Fig. 6 (a-c), fast reduction of β suppresses the epidemic
before any appreciable progress towards herd immunity was made. Mitigation needs to be
strong and sustained to be compatible with the data. By July, the population reaches only
about 6−7% of herd immunity in this case. Note that this is the only scenario of the classic
SIR model with a homogeneous population (α → ∞) that could be compatible with the
data.
15
(a) (b) (c)
(d) (e) (f )
(g) (h) (i)
Figure 6: Scenarios of mitigation. (a)-(c) Early mitigation by strong reduction of β for a homo-
geneous population (large α limit). The new cases per day are shown in (a) as symbols. A fit of
the mitigated model is shown as solid lines. The solution for same parameter values R0 = 2 and
γ = 0.24 but without mitigation is shown as dotted lines. The corresponding cumulative numbers
of cases are shown in (b). Herd immunity levels corresponding to these solutions are indicated as
horizontal dashes lines. The time dependence of β(t) are shown in (c) as solid lines. The time
courses of β inferred from the data is shown as symbols. Mobility data indicating social activities
in Germany relative to baseline values are shown in orange for comparison. (d)-(f) same plots as
in (a)-(c) but for a moderate mitigation and heterogeneous population with R0 = 2, γ = 0.24 and
α = 0.1. (g)-(i) Heterogeneous population with mild mitigation and release leading to almost herd
immunity. Red symbols and lines correspond to the case of all reported infections, blue data and
lines correspond to reported infections of fatal cases.
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For heterogeneous populations with α . 0.2, scenarios with milder mitigation and with
infection levels closer to herd immunity are compatible with the data, see Fig. 6 (d) and
(g). A case of moderate mitigation with α = 0.1 is shown in Fig. 6 (d-f). The population
in this case reaches by July 1st about ∼ 45% of herd immunity. A sustained mitigation is
needed to account for the data, albeit with smaller magnitude compared to the first case.
If the epidemic starts slightly earlier (3 days for the case shown in Fig. 6(g-i) as compared
to (d-f)), the population reaches ∼ 95% of herd immunity by July 1st. Here, mitigation has
the effect to reduce the cumulative number of infections as compared to a non-mitigated
case (C/N = 5.8% compared to 11% by July 1st). This reduction of cumulative infections
C results from a reduction of the number of infectious individuals I at the point when herd
immunity is reached. In the absence of mitigation, I reaches its maximum when C = CI ,
whereas mitigation can reduce I to small numbers as herd immunity is reached, preventing
further infections. The minimal number of infections that can be achieved by temporary
mitigation is CI , which is up to 50% smaller than the long lime limit C∞ in an unmitigated
epidemic (see Fig. 2c).
The scenarios of temporary reduction of β could capture the mitigation effects of social
distancing measures. To relate the inferred time dependence of β to measures of social
activity, we show in Fig. 6(c),(f) and (i), β(t) together with mobility data from Ref. [31]
for comparison, see Appendix H. This mobility data shows a sharp decline and a slow but
steady return to the initial state roughly in line with inferred changes of β(t).
The three scenarios differ in the fraction of herd immunity they reach by July 1 and
therefore in their future trajectories. However, β(t) was adjusted by a fitting procedure
such that all scenarios are consistent with the data on reported infections. This reveals
that it can be difficult to distinguish effects of heterogeneity leading to a time dependent
average susceptibility x¯ from mitigation effects corresponding to time-dependent β. Indeed
our analysis shows that changes in mitigation strength can be compensated to some degree
by changes of heterogeneity described by α.
IV. DISCUSSION
We have presented a generalization of the classic Susceptible-Infected-Removed model
for epidemic waves, which adds one new parameter to the model that captures population
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heterogeneity by a power-law exponent α. This exponent describes the power law that
characterizes the distribution of susceptibility in the population s(x) ∼ x−1+α for small x.
A special case for such distributions is the gamma distribution. Gamma distributions have
been used before to describe heterogeneous populations [13, 15, 16]. Here, we have shown
that gamma distributions have the special properties that they are both shape invariant
under the dynamics and attractors of the dynamics for power-law distributions. This implies
that for each α there exists a class of distributions with the same power law at small x which
share the same limiting dynamics and distribution. The generalization of the SIR model
introduced here captures the effects of these power laws by the parameter α in a generic
way. Note that this generalization does not change the simplistic nature of the SIR model
and does not change its numerical or analytical complexity.
For α > 1, population heterogeneity is weak and in the limit of large α, one recovers
the classic SIR model of homogeneous population, see Fig 1 (a)-(c). For α < 1 population
heterogeneity plays a key role in limiting the peak of the epidemic wave. We show that as
a result of strong population heterogeneity (small α), the wave peaks when only a small
minority of individuals have been infected, see Fig. 1 (d)-(f). The herd immunity level, the
point where the epidemic dies down spontaneously becomes very small for small α, see Eq.
(19). Thus our model shows that for small α, an epidemic wave can die out after reaching
only a small fraction of the population even though a majority of the population is still
susceptible. In this case the population is stable with respect to introducing new infected
individuals because the average susceptibility x¯ has dropped significantly, see Fig. 1 (f).
Many properties of the nonlinear wave in this generalized model can be obtained exactly
as a function of α and in the limit of small α. Numerical solutions can be generated quickly
and efficiently. In a heterogeneous population the average susceptibility x¯ stays almost
constant at early stages of the epidemic where the number of new cases grows exponentially
with rate λ0 = γ(R0−1). At this stage the dynamics is the same as in the classic model and
independent of α. However, x¯ then drops rather quickly and the epidemic waves thus reaches
its peak and dies down, see Fig. 1 (b) and (f). This sudden drop in average susceptibility
results from a shift of the distribution of susceptibility. The most susceptible individuals
are removed from the dynamics at higher rates than those with low susceptibility. This
leads to a rapid reduction of the average susceptibility until it has dropped to a low value
where the time dependent reproduction number R falls below 1, see Eq. (17). The wave
18
then dies down at rate λ∞ and the average susceptibility approaches a final value x¯∞. Thus
the qualitative behavior of the classic SIR model is unchanged and the key parameters, the
recovery rate γ and the basic reproduction number R0 have the same values and properties.
However, the power-law distribution of susceptibility can dramatically change the peak of
the epidemic and alters the precise shape of the wave. The dynamics effectively shifts the
edge of the susceptibility distribution, see inset in Fig. 4 (f), which changes the stability
of the population from prone to an exponentially growing wave to a stably decaying wave
without requiring a large number of infections.
The simple SIR model does not aim to capture details such as the population structure,
the geography or human travel. In the spirit of statistical physics it is based on the idea
that the collective behaviors of many individuals give rise to an emergent epidemic wave
with robust and generic features that can be captured by a simplified model that focuses on
key aspects. Here we show that power-law heterogeneity is a key factor that should not be
left out.
We apply our model to data on the SARS-CoV-2 epidemic in Germany in 2020. The data
from Germany provides time stamps on reporting dates of infections and reporting dates of
infections that later are fatal. Surprisingly, the data for fatal cases is well described by the
heterogeneous SIR model with constant parameters and small α but not by the classic SIR
model with constant parameters. In the case of SARS-CoV-2, immunological data suggests
that only a minority of the population exhibits antibodies [27, 29, 30]. This is consistent
with a fit of our model to the data using a small value of α. The data on all reported
cases can also be captured by the model, but the fit is less convincing. Comparing the
data on all reported cases to the data on the time course of cases that are fatal reveals some
differences. Clearly the fatal cases represent a different sampling as these cases correspond to
predominantly old individuals and therefore measure a different quantity. However, starting
from all reported cases and then using the fatal outcome as a second criterion could reduce
biases due to changes in testing rates, testing strategies as well as testing errors.
An epidemic wave does not progress under constant conditions but is subject to changes
such as mitigation measures and seasonal effects. We use our model in comparison with
the data from Germany to investigate different scenarios of mitigation that correspond to
different level of immunity in the population. In the case of a homogeneous population the
data can only be accounted for if mitigation is strong and suppresses the epidemic far below
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herd immunity Fig. 6 (a)-(c). This scenario further requires mitigation to be sustained and
it leads to a fragile and unstable state when mitigation measures are relaxed.
In the case of heterogeneous populations, intermediate scenarios are possible which stay
below herd immunity or just reach herd immunity, see Fig. 6 (d)-(i). In the latter example
shown in Fig. 6 (g)-(i), mitigation effectively reduces the total number of infections by
keeping immunity just at herd immunity level, leading to a stable state where mitigation
can be safely relaxed. This is a desirable outcome because the number of infections could
be reduced by mitigation by up to 40% without the need of sustaining mitigation, see Fig.
2 (c).
When discussing rapidly evolving epidemics such as SARS-CoV-2, herd immunity is often
not considered to be reachable as it is predicted to require an unacceptably high fraction
of cumulative infections [32]. Interestingly, the picture changes dramatically if a strongly
heterogeneous population is considered. In this case herd immunity can be reached rather
quickly while a large majority of the population is still susceptible. This raises the question
of what are the features that are variable and that give rise to heterogeneity and how
widely they are expected to vary in the population. One possibility is that differences
of susceptibility stem from differences in the abilities of immune systems of susceptible
individuals to react to a new pathogen. In addition to adaptive immunity related to the
presence of specific antibodies, many individuals show a T-cell response to SARS-CoV-2
[24]. This response could for example be due to less specific cross reactions related to earlier
encounters with related viruses [23].
Here we have focused on data from Germany until July 2020 because it provides detailed
information that is not available in most countries. Furthermore, Germany has relatively
few reported infections and deaths per capita. Our work shows that even this rather mild
manifestation of the epidemic can be captured by a heterogeneous SIR model with mild
mitigation. The data of newly infected cases with fatal outcome can even be explained
in a strongly heterogeneous population without considering any mitigation effects at all.
This implies that in order to quantify the effects of mitigation, population heterogeneity
has to be taken into account. In order to disentangle effects from heterogeneity and from
mitigation the combination of different types of information is important. For example,
analyzing in different countries the circumstances under which different sero-prevalence levels
or multiple epidemic waves are observed could be key to understand the roles of mitigation
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and heterogeneity.
Appendix A: Properties of the homogeneous SIR model
For a homogeneous population with x¯ = 1, the SIR model given in Eqns. (1-2) can be
written as
I˙ = (1− I0
N
)βIe−τ − γI (A1)
τ˙ = β
I
N
(A2)
with S = (N − I0) exp(−τ) with I(0) = I0 and τ(0) = 0. We therefore have dI/dτ = I˙/τ˙ =
(N − I0)e−τ −N/R0, where R0 = β/γ. For constant β this implies
I(τ) = I0e
−τ +N(1− e−τ )− Nτ
R0
(A3)
We can eliminate τ and find
I
N
= 1− S
N
+
1
R0
ln
S
N − I0 . (A4)
The maximum Imax = I(τI) with I
′(τI) = 0, where the prime denotes a τ -derivative,
occurs for
τI = ln
(
R0(1− I0
N
)
)
. (A5)
Therefore we the maximal number of infected individuals reads
Imax = N [1− 1
R0
− 1
R0
ln
(
R0(1− I0
N
)
)
] . (A6)
At the maximum Imax, we have dI/dS = 0, which implies
S(τI)
N
=
1
R0
(A7)
At long times, the infection dies out when I(τ∞) = 0 with (1 − I0/N) exp(−τ∞) =
1−τ∞/R0 and S∞ = (N−I0) exp(−τ∞). We therefore have S∞/N = 1+ln(S∞/(N−I0))/R0
and
S∞
N
= − 1
R0
W
(
−R0e−R0(1− I0
N
)
)
. (A8)
where W (z) denotes the 0-branch of Lambert W-function. The time dependent solution
τ(t) can be obtained from Ndτ/I(τ) = βdt via∫ τ
0
dτ ′
1− (1− I0/N)e−τ ′ − τ ′/R0 = βt . (A9)
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To discuss empirical data, we consider the time-course of the rate of new cases J =
βIS/N . We have J˙/J = βK with
K = (1− I0
N
)e−τ − 1
R0
− I
N
(A10)
The maximum Jmax = J(τJ) is reached for K(τJ) = 0 which implies
τJ = W−1
(
−(1− I0
N
)2R0e
−(R0+1)
)
+R0 + 1 (A11)
where W−1(z) denotes the −1 branch of the Lambert W -function with W (z)eW (z) = z. At
the maximum Jmax of J we have S˙I + I˙S = 0 and therefore
S(τJ) = − 1
2R0
W−1
(−2R0e−1−R0) (A12)
I(τJ) = S(τJ)− 1
R0
(A13)
and therefore
Jmax = βS(τJ)(
S(τJ)
N
− 1
R0
) (A14)
Near the maximum of the rate Jmax with J˙ = 0 we have A2 = J¨/J |t=tJ and A3 =
...
J /J |t=tJ .
For the homogeneous SIR model, we have
A2 = −γ
2
2
[
1 +W−1
(−2R0e−1−R0)] [2 +W−1 (−2R0e−1−R0)] (A15)
A3 =
γ3
4
[
2 +W−1
(−2R0e−1−R0)]2 . (A16)
Appendix B: Distributions of infection susceptibility in the population
For an initial distribution s0(x) of susceptible individuals with susceptibility x, we define
S(τ) =
∫∞
0
dxs0(x)e
−τx. We can then write the dynamics of the epidemic spreading given
in Eqns (1) and (2) as two equations for I(t) and τ(t)
I˙ = −β I
N
dS
dτ
− γI (B1)
τ˙ = β
I
N
(B2)
with initial values I(0) = I0, τ(0) = 0 and S(0) = N−I0. The number of susceptible at time t
is then given by S(t) = S(τ(t)). Defining the cumulant-generating function Γ(τ) = − lnS(τ),
we have
x¯ =
d
dτ
Γ (B3)
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and the nth cumulant of x is for n > 1 given by
〈xn〉c = (−1)n+1 d
n
dτn
Γ (B4)
The classic case with homogeneous population then corresponds to s0(x) = (N − I0)δ(x),
see Appendix A.
Here we consider distributions which exhibit a power-law behavior for small x with s0 ∼
x−1+α. For α > 0 the power law must be cut off at large x > x0 for the distribution to be
normalizable. From ∂τs = −xs, we have s(x, τ) = s0(x)e−τx which for τ  1/x0 approaches
s(x, τ) ∼ x−1+αe−τx. The moments of this distribution can be obtained from the cumulant
generating function Γ(τ) = − ln ∫∞
0
dxx−1+αe−τx = −α ln τ + const. The cumulants of this
distribution are 〈xn〉c = ατ−n(n − 1)!. Using x¯ = α/τ , the susceptibility thus approaches
for large τ the limiting distribution
s(x, τ) ∼ x−1+αe−αx/x¯ (B5)
which is the gamma distribution.
Appendix C: The generalized SIR model with population heterogeneity
We have shown in Appendix B that for susceptibility distribution with a power law at
small x the gamma distribution is an attractor of the dynamics. We therefore choose at
time t = 0 a gamma distribution with average x¯ = 1 as initial condition. It is given by
s0(x) = (N − I0) α
α
(α− 1)!x
−1+αe−αx (C1)
Here (α − 1)! denotes Euler’s gamma function. Note that in the limit of large α, this
approaches the homogeneous case with s0(x) ' δ(x−1). We then have S(τ) = (N − I0)(1 +
τ/α)−α and S ′ = −(N − I0)(1 + τ/α)−(1+α), where the prime denotes a derivative with
respect to τ . As time evolves, the shape of the distribution s(x, t) is time independent.
Indeed, with ∂τs = −xs we have s(x, τ) = s0(x)e−τx and thus
s(x, τ) = (N − I0)x¯−1+αf(x/x¯) (C2)
with x¯(τ) = (1 + τ/α)−1. The time-invariant distribution is then given by
f(z) =
αα
(α− 1)!z
−1+αe−αz (C3)
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The dynamic equation of the heterogeneous SIR model read
I˙ = Iβ(1− I0
N
)(1 +
τ
α
)−(α+1) − γI (C4)
τ˙ = βI/N . (C5)
Defining I ′ = I˙/τ˙ , we have
I ′ = (N − I0)(1 + τ
α
)−(α+1) − N
R0
(C6)
For constant β, we then have by integrating over τ
I = I0(1 +
τ
α
)−α +N(1− (1 + τ
α
)−α)− Nτ
R0
(C7)
The maximum of I is reached for τ = τI with I
′ = 0 and thus
(1 +
τI
α
)α+1 = (1− I0
N
)R0 (C8)
We thus obtain
Imax
N
= 1− 1
R0
− 1
R0
(1 + α)[((1− I0
N
)R0)
1
1+α − 1] . (C9)
The epidemic ends at long times for I(τ∞) = 0, for which
(1− I0
N
)(1 +
τ∞
α
)−α = 1− τ∞
R0
(C10)
with S∞ individuals that remain susceptible. This quantity obeys
R0
S∞
N
+ α(1− I0
N
)
1
α (
S∞
N
)−
1
α = R0 + α . (C11)
We then find
S∞
N
=
R0 + α
R0
F
 α
R0 + α
[
R0(1− I0N )
R0 + α
] 1
α
,
1
α
 , (C12)
Where the function F (z, ν) is defined as the inverse of the function xν(1−x) via the condition
F ν(1 − F ) = z. Finally, using Ndτ/I(τ) = βdt, the time dependent solution τ(t) can be
written as ∫ τ
0
dτ ′
1− (1− I0/N)(1 + τ ′/α)−α − τ ′/R0 = βt . (C13)
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Appendix D: Dynamics of the rate of daily new cases
Data on the dynamics of the epidemic typically provides information about new cases
reported per day. We therefore consider the rate of nex cases J = −βIS ′/N , where the
prime denotes a τ derivative. Using I ′ = −S ′ −N/R0, we have
I(τ) = I0 + S(0)− S(τ)− Nτ
R0
. (D1)
We then write
J˙
J
= βK (D2)
with
K = −S
′
N
− 1
R0
+
I
N
S ′′
S ′
. (D3)
We then have
K ′ = −S
′′
N
+
I ′
N
S ′′
S ′
+
I
N
S ′′′S ′ − S ′′2
S ′2
(D4)
The maximum of J occurs at τ = τJ with K(τJ) = 0. We thus have A2 = (J¨/J)|t=tj = βK˙
and A3 = J
−1(d3J/dt)|t=tj = βK¨.
Plugging in S(τ) = N(1 + τ/α)α for the heterogeneous SIR model with I0 << N , yields
K = (1 +
τ
α
)−1
((
1 +
τ
α
)−α
− α + 1
α
I
N
)
− 1
R0
(D5)
=
1
α + τ
((
1 +
τ
α
)−α
(2α + 1)− (α + 1)(1− τ
R0
)
)
− 1
R0
(D6)
At the maximum in J , we have K = 0, yielding
2α + 1
(α + 1)
(
α
R0
+ 1
) = (1 + τJ
α
)α [
1− α
2
(α + 1)(α +R0)
(
1 +
τJ
α
)]
(D7)
Using the function F (z, ν) defined by F ν(1− F ) = z, we can solve this for τJ :
τJ =
(α + 1)(α +R0)
α
F
 2α + 1
(α + 1)
(
α
R0
+ 1
) [ α2
(α + 1)(α +R0)
]α
, α
− α (D8)
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(a) (b)
Figure 7: Normalized coefficient A3 =
...
J /J at the peak of new cases per day. (a) The ratio A3/λ
3
0
as a function of R0 is shown for different values of α. (b) The ratio A3/λ
3∞ as a function of R0
for the same values of α. The dashed lines represent the values inferred from the data shown in
Fig. 3 for all cases (red) and fatal cases (blue). The shaded colored regions correspond to the
uncertainties of the fits to the data.
This allows us to compute A2 and A3
A2 =
J¨
J
∣∣∣∣
τ=τJ
= βK˙ =
γ2(1 + α)
(α + τJ)2
(
1 +
τJ
α
)−2α [
(R0 − τ)
(
1 +
τJ
α
)α
−R0
]
[
−(1 + 2α)R0 + (α +R0)
(
1 +
τJ
α
)α]
(D9)
A3 =
...
J
J
∣∣∣∣
τ=τJ
= βK¨ =
γ3(1 + α)
(α + τJ)3
(
1 +
τJ
α
)−3α [
(R0 − τJ)
(
1 +
τJ
α
)α
−R0
]
[
− (α +R0)(α + 2R0 − τJ)
(
1 +
τJ
α
)2α
+ (1 + α)R0
(
1 +
τJ
α
)α
(3α + 2(2 + α)R0 − (1 + 2α)τJ)
− 2(1 + α)(1 + 2α)R20
]
(D10)
The parameters λ0, λ∞, A2 and A3 can be obtained from linear and cubic fits to the
logarithm the number of daily reported cases Jrep. For these fits, time intervals corresponding
to initial exponential growth (Ti), peak Tp and final decay Tf need to be defined. We use
the time point trepm , where Jrep reaches its maximum as a reference point relative to which
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the intervals are given by:
Ti =[t
rep
m − 3∆t, trepm −∆t]Tp = [trepm −∆t, trepm + ∆t]Tf =[trepm + ∆t, trepm + 3∆t] (D11)
These time intervals are further reduced depending on the used data and ∆t such that all
time points before the last day with Jrep = 0 prior to t
rep
m and after the first day Jrep = 0
after trepm are excluded. The fits in Fig. 3 and the dashed horizontal lines in Fig. 5 and 7
correspond to fits with ∆t = 19days. The shaded areas in Fig. 5 and 7 depict the range of
parameter values one obtains for fits with 10days ≤ ∆t ≤ 20days.
Appendix E: Small α limit for heterogeneous populations
For small α the system reaches a well defined limiting dynamics that can be expressed
analytically. We start from I(τ) for small I0/N
I
N
= 1− (1 + τ
α
)−α − τ
R0
(E1)
which for small α becomes
I
N
' α ln(1 + τ
α
)− τ
R0
. (E2)
The maximum of I occurs at τ = τI when I
′ = 0 or τI/α ' R0 − 1. We thus have
Imax
N
' α(lnR0 + 1
R0
− 1) . (E3)
Similarly, using CI/N = 1− (1 + τI/α)−α, we find for small α
CI
N
' α lnR0 (E4)
At long times, we have I(τ∞) = 0, where (1 + τ∞/α)−α = 1 − τ∞/R0. For small α this
implies α ln(1 + τ∞/α) ' τ∞/R0 and thus S∞ = (N − I0)x¯α∞ and λ∞ = βx¯∞ − γ, where
x¯−1∞ = −R0W−1(−
e−1/R0
R0
) . (E5)
In the limit of small α, u = τ/α is finite. The limiting function u(t) for small α can be
expressed as ∫ u
0
du′
ln(u′ + 1)− u′/R0 + i0 = βt , (E6)
where i0 = I/(αN) in the limit α = 0. The number of susceptible then becomes
S
N
' 1− α ln(1 + u) . (E7)
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Finally we discuss the maximum of the rate of new cases J = Jmax. We have J˙/J = βK,
where
K = (2 +
1
α
)(1 +
τ
α
)−(α+1) − 1
R0
+
α + 1
α
1− τ/R0
1 + τ/α
(E8)
At the maximum of J , τ = τJ with
(2α + 1)(1 +
τJ
α
)−α =
α
R0
(1 +
τJ
α
) + (α + 1)(1− τJ
R0
) (E9)
Defining x¯J = (1 + τJ/α)
−1 we have in the limit of small α
x¯J = exp(
1
R0
− 1) . (E10)
The value of J at the maximum is
Jmax
N
= αγR0x¯J(− ln x¯J − 1− x¯J
R0x¯J
) . (E11)
We determine A2 = J¨/J = β
2K˙ and A3 =
...
J /J = β3K¨, with K˙/β = K ′I/N and K¨/β2 =
K ′′I2/N2. We then find
A2 = −γ2R20x¯2J(− ln x¯J −
1− x¯J
R0x¯J
) (E12)
A3 = 2γ
3R30x¯
3
J(− ln x¯J −
1− x¯J
R0x¯J
)2 . (E13)
We also have
A22
A3
=
γR0x¯J
2
(E14)
and
A23
A32
= 4(− ln x¯J − 1− x¯J
R0x¯J
) . (E15)
Appendix F: Mitigation in the heterogeneous SIR model
We now consider the case where the rate of infections β(t) becomes time dependent be-
cause of overall changes of conditions such as seasonal effects or measures of social distancing.
Using I ′ = −S ′ +N/R0, we have λ = I˙/I = −βS ′/N − γ and the reproduction number
R = − β
β0
R0
S ′
N
. (F1)
where β0 = β(t = 0) and R0 = β0/γ. The epidemic can be mitigated by a reduction of β over
time. However if the mitigation is relaxed the epidemic can grow again. As the epidemic
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advances, τ increases as τ˙ = βI/N . Growth of infection number is no longer possible for
τ > τI with
− S ′(τI) = 1
R0
(F2)
Thus the condition τ > τI defines herd immunity conditions where the epidemic can no
longer grow. If mitigation sets in early, before τ = τI , the epidemic is slowed and it takes
more time to reach herd immunity. in this case a new wave starts after mitigation is relaxed.
If mitigation occurs for τ > τI , mitigation facilitates the decay of infections by reducing
λ∞ = −(β∞/β0)R0S ′(τ∞) − γ as compared to the value λ∞ = −R0S ′(τ∞) − γ without
mitigation.
Appendix G: Inferring β(t) from reported cases
For a given time course of infections, there always exists a function β(t) such that the
SIR model follows this time course. We first consider the classic SIR model. A change in
the rate of new infections J = βIS/N can be decomposed in three different contributions,
d
dt
ln J =
β˙
β
+
I˙
I
+
S˙
S
. (G1)
In the case of an early mitigation, S ≈ N and thus S˙/S ≈ 0. Together with Eq. (2), we
find
d
dt
ln J =
d
dt
ln β + β − γ. (G2)
This provides a differential equation for ln β if ln J(t) is given, which does not require
knowledge of the amplitude of J . We infer β(t) for each day, using the initial value β(0) =
0.48 days−1 at March 15. We use an iterative scheme to calculate the rate for the next day
as
ln β(i+ 1) = ln β(i) + ln Jobs(i+ 1)− ln Jobs(i)− β(i) + γ, (G3)
where ln Jobs(i) = (1/7)
∑3
∆t=−3 Jrep(i + ∆t) is a running average over seven days of the
number of reported cases.
For the two scenarios of a later mitigation, the heterogeneous SIR model was considered
with J = βI(1− I0/N)(1 + τ/α)−(α+1). We then have
d
dt
ln J =
d
dt
ln β +
d
dt
ln I − α + 1
α
(1 +
τ
α
)−1
βI
N
. (G4)
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Figure 8: Mobility changes for a representative set of commonly visited places in Germany up to
July 1 2020 from [31].
Again, this equation can be used to construct an iterative scheme to infer β(t). For given
initial number of infected individuals on March 15 I(0), we can iteratively obtain the sub-
sequent values as
ln τ(i+ 1) = ln τ(i)+
β(i)I(i)
Nτ(i)
, (G5)
ln I(i+ 1) = ln I(i)+ β(i)(1− I0
N
)(1 +
τ(i)
α
)−(α+1) − γ, (G6)
ln β(i+ 1) = ln β(i)+ ln
Jobs(i+ 1)
Jobs(i)
− ln I(i+ 1)
I(i)
+
α + 1
α
(1 +
τ(i)
α
)−1
β(i)I(i)
N
. (G7)
The starting value of τ(0), can be derived by inverting Eq. (C7) for I(τ(0)) = I(0).
Appendix H: Mobility Data
Data concerning the changes in mobility of the population has been provided by Google
[31]. The data reports the changes compared to a baseline of visits and length of stay at
different places. The baseline depends on the specific day of the week and refers to the
median value, for the corresponding day of the week, during the 5-week period Jan 3Feb 6,
30
2020. Fig. 8 shows these changes for Germany for a representative number of categories.
These categories are defined in [31] as follows: “Grocery and pharmacy: Mobility trends for
places like grocery markets, food warehouses, farmers markets, specialty food shops, drug
stores, and pharmacies. Transit stations: Mobility trends for places like public transport
hubs such as subway, bus, and train stations. Retail and recreation: Mobility trends for
places like restaurants, cafes, shopping centers, theme parks, museums, libraries, and movie
theaters. Residential: Mobility trends for places of residence. Workplaces: Mobility trends
for places of work. The residential category shows a change in duration while the other
categories measure a change in total visitors.”
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